All patients were followed for a minimum of six months postoperatively. The principal outcome measures were re treatment rate, safety, efficacy in terms of
uncorrected distance visual acuity (UDVA) and uncorrected reading ability (vocational
reading test), patient satisfaction, stability and predictability. Results: 76
eyes of 38 patients were treated. 42% of patients (16 patients) that were
treated required at least one re-treatment.
Endophthalmitis is a severe
inflammation of the inner eye's structures, caused by an exogenous or
endogenous infection with microorganisms which can multiply rapidly. It occurs most frequently after intraocular surgery. Moreover, it can also be a
consequence of a penetrant eye injury or a hematogenous dissemination of
microorganisms. The most common pathogens of this inflammation are bacteria,
next to fungi and less frequently parasites.
The occurrence, severity and
clinical presentation of endophthalmitis depend on the way of infection, the
number and virulence of pathogenic bacteria, as well as the patient's immunity
state. The type of endophthalmitis can suggest the possible causative agent.
Furthermore, it can help determine therapeutic approach or antibiotics to
choose. The more virulent are the causative agents, the early the symptoms and
signs of endophthalmitis appear.
Epidermal cysts are benign slow
growing tumors resulting from proliferation of epidermal cells. Usually cysts
are asymptomatic; however, they may become inflamed or secondarily infected.
Epidermal cysts are solitary sub epithelial cysts, are slowly progressive and firm in consistency. They are most commonly seen on the face, scalp, neck and
trunk. Epidermoid cysts are frequently seen on the upper eyelid, mainly on the
conjunctiva or on the skin. This may be misdiagnosed as chalazion or sebaceous
cyst. Surgical excision of the cyst in toto is the treatment of choice or else
there will be recurrence, granulomatous reaction or foreign body reaction.
Myelinated
retinal nerve fibers (MRNFs) are developmental anomalies of the retina that
appear as white to grey-white striated patches with feathery edges, often
distributed around or contiguous with the optic disc and surrounding the
vascular arcades. Based on a fundus photography study including 5789 patients,
Kodama et al. reported that MRNFs occur in approximately 0.57% of the
population, most often involving superior and inferior-temporal per papillary
areas. No MRNFs were discovered in the macula, and 7.7% were bilateral.
To answer this question: I
certainly hope not, at least not always. Without a doubt over the past several
years the contact lens industry has brought forth numerous new materials,
designs, and modes of contact lens manufacturing. But that should not translate into a universal switch from the “old” to the “new”. I would like to share some
specific instances where older lens materials and designs should still have a
place in your practice.